AUS
NZ
UK
CA
USA
IND
Healt
What is pushing CSL’s share price on ASX?
July 11, 2022 05:38 PM AEST| By RitwikaThe CSL shares were trading in green today during the morning hours even though the healthcare sector was trading in red. We have discussed the probable causes of share price gain in our article today.
_07_07_2022_05_54_58_776933.png)
How are healthcare firms RMD, COH, PME, FPH faring on ASX?
July 07, 2022 03:47 PM AEST| By Sukriti NairHealthcare sector being a defensive sector gains attention in times of market volatility. In the last one month the healthcare index has gained more than 4%. In this backdrop let us see the latest performances of ResMed Inc (ASX:RMD), Cochlear Limite...
NUH, IIQ: ASX medical device stocks that kicked off July on bright note
July 04, 2022 06:35 PM AEST| By Aditi SarkarHighlights,The S&P/ASX 200 kicked off July with a loss of 0.43%.,Nuheara Limited (ASX: NUH) has inked a strategic collaboration and cornerstone investment with Realtek, a Taiwan-based company.,Inoviq Limited (ASX: IIQ) has secured a US patent valid t...
PGC, MVF, AJJ: Healthcare penny stocks with decent price returns in last 52 weeks
June 30, 2022 05:43 PM AEST| By Aditi SarkarHighlights,Over the last five days, the S&P/ASX200 has gained 1.82% but is down 10.7% over the last 52 weeks,The benchmark of the healthcare index, the S&P/ASX 200 Health Care, is down 11.16% over the last 52 weeks,Paragon offers a generous dividend...
RSH, AVR, NTI: Best performing ASX healthcare equipment stocks in June
June 28, 2022 12:03 PM AEST| By Aditi SarkarHighlights,The S&P/ASX 200 Health Care closed on Monday with a gain of 1.25%.,The healthcare index has lost 1.55% over this month.,RSH, AVR, and NTI are three stocks from ASX healthcare that have outperformed the healthcare index and are up by more t...
CGS, GLH, PME: ASX healthtech stocks with modest 3-year returns
June 27, 2022 07:01 PM AEST| By Aditi SarkarHighlights,The fast-paced digital transformation has revolutionised the healthcare sector,Technology is penetrating all aspects of healthcare services, be it staff and facility management or patient care and diagnosis,This month Pro Medicus (ASX: PME...
Big data in Healthcare- Where is Australia placed?
June 24, 2022 06:18 PM AEST| By Aditi SarkarHighlights,An analysis of big data can provide insights for improved decision-making and making strategic business moves,Improved patient outcomes, managing mass diseases, and predictive analysis in healthcare are some of the applications of big data...
_06_23_2022_07_43_04_667588.jpg){kind=logo}
What is boosting CSL Limited’s (ASX:CSL) share price?
June 23, 2022 05:37 PM AEST| By Sukriti Nairiggest ASX-listed healthcare stock, CSL Limited (ASX:CSL) has turned north recently. In last five trade days, CSL share price has gained 4.67%. CSL shares have notably moved up from their three-month low-price level. Despite delays in the acquisitio...
RMD, CSL, COH, VRT: How are these healthcare stocks faring at ASX?
June 22, 2022 03:40 PM AEST| By Priyanka PayalThe Australian share market opened on a positive note today as the ASX200 was up 0.108% at 6530.900 points at 11:57 AM AEST. Eight of 11 sectors are higher today, where the Utilities, energy and healthcare are the best performers.
ResApp (ASX:RAP) shares nosedive 33% today; here’s why
June 21, 2022 02:54 PM AEST| By Sonal GoyalHighlights ResApp’s ‘not so positive’ COVID-19 data confirmatory study results are dragging the share price down on ASX. The unfavourable study outcome has also resulted in a drop in the scheme consideration from Pfizer. The .....
Volpara (ASX:VHT) inks deal with Microsoft, here’s how shares reacted
June 21, 2022 01:37 PM AEST| By Sonal GoyalDigital health solutions developer, Volpara Health Technologies Limited (ASX:VHT) shared today that it has joined hands with Microsoft to speed up the research and development of the products that detect breast arterial calcifications (BACs). Volp.....
CSL, RHC, VRT: ASX healthcare stocks with sustainable returns
June 16, 2022 03:37 PM AEST| By Aditi SarkarHighlights The S&P/ASX200 hit a new 52-week low on Wednesday The year-to-date, one-year, and three-year returns of the S&P/ASX200 Health Care stand at 14.76%, -14.71% and 4.94%, respectively CSL, Ramsay, and Virtus are some stocks from.....
SW1, SNZ, HSC : How are these ASX aged care stocks faring?
June 16, 2022 11:53 AM AEST| By Aditi SarkarHighlights The 2022-23 budget of Australia invested AU$522 million in the aged care reforms Swift Networks implemented an agreement with Hubify Limited worth AU$1.5 million In 2021, SNZ reported a 136% increment in net profit after tax In May.....
ResMed (ASX:RMD) to acquire MEDIFOX DAN in US$1.0B deal
June 15, 2022 03:25 PM AEST| By Sonal GoyalMedical device manufacturing company, ResMed Inc (ASX:RMD), has shared on Wednesday, that it will acquire MEDIFOX DAN for US$1.0 billion, under a definitive agreement. MEDIFOX DAN is a leader in out-of-hospital software solutions providers. ResMed.....
Pro Medicus (ASX:PME) inks two contract renewals worth AU$47M
June 14, 2022 01:24 PM AEST| By Sonal GoyalHighlights Pro Medicus has signed a renewal contract with Sutter Health for another seven years. A renewal contract is also inked with Wellspan Health for further five years. The share price of Pro Medicus has gained by over 650% in last 5 yea.....
Healthcare value stocks from ASX All Ordinaries: HLS, MVF, SHL, ANN
June 13, 2022 12:07 AM AEST| By Aditi SarkarHighlights Value stocks trade at a lower price corresponding to their fundamentals A high dividend yield and low P/B P/E ratios are common features of value stocks Healius reported a 100% increment in underlying unaudited EBITDA YTD to May 202.....
Pro Medicus signs US$28M contract with Allina Health; how are shares faring?
June 02, 2022 10:54 AM AEST| By AshishHighlights Pro Medicus signed a 7-year contract with a Minneapolis-based firm Allina Health. The deal with Alline Health is worth AU$28 million. The deal is expected to provide a unified diagnostic imaging platform across the network...
Recent updates from ASX healthcare stocks DXB and GLH
June 01, 2022 04:01 PM AEST| By Aditi SarkarHighlights Dimerix recruits the first subject for its DMX-200 phase 3 trial in patients with FSGS kidney disease. FSGS has a huge market opportunity as in the US alone, end stage renal failure amounted to an estimated cost of US$55 billion per .....
Mesoblast (ASX:MSB) posts US$23.1M third-quarter loss; how are shares faring?
June 01, 2022 11:14 AM AEST| By AshishHighlights Mesoblast’s loss after tax for the third quarter FY2022 was US$21.3 million. Total revenue rose 5% from the comparative quarter last year to US$2 million. Despite the loss, Mesoblast’s share price was trading a...
CSL, RHC, SHL: 3 ASX health care stocks on investors’ watchlist
May 31, 2022 02:20 PM AEST| By Aditi SarkarHighlights CSL has the largest market capitalisation (AU$131.32 billion) in the ASX health care space as of 31 May 2022 In 2020/21, CSL invested US$1,001 million in R&D activities Sonic reported revenue growth of 7% and net profit growth o.....
Advertise your brand on Kalkine Media